Respiratory epithelial adenomatoid hamartoma with nasal polyps affects dupilumab efficacy

Rhinology. 2022 Apr 1;60(2):148-151. doi: 10.4193/Rhin21.359.

Authors

T Takeda¹, N Yanagi¹, N Fukasawa², E Mori¹, M Maeda¹, R Sakaguchi², M Tei¹, K Omura¹, N Otori¹

Affiliations

¹ Department of Otorhinolaryngology, Jikei University School of Medicine, Japan.
² Department of Pathology, Jikei University School of Medicine, Japan.

PMID: 35174813
DOI: 10.4193/Rhin21.359

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Diagnosis, Differential
Hamartoma* / diagnosis
Hamartoma* / drug therapy
Humans
Nasal Polyps* / complications
Nasal Polyps* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
dupilumab